Class II · Moderate risk
DISCOUNT drug mart
Presence of foreign substance: small metallic particles in chewable tablets.
FDA Drug Recalls
18,003 recalls, newest first
Class II · Moderate risk
CAREone
Presence of foreign substance: small metallic particles in chewable tablets.
Class II · Moderate risk
CAREone
Presence of foreign substance: small metallic particles in chewable tablets.
Class II · Moderate risk
MARKET BASKET ANTACID Calcium Carbonate 1000 mg
Presence of foreign substance: small metallic particles in chewable tablets.
Class II · Moderate risk
24/7 life BY 7-ELEVEN
Presence of foreign substance: small metallic particles in chewable tablets.
Class II · Moderate risk
Extra strength Antacid Calcium Carbonate 750 mg
Presence of foreign substance: small metallic particles in chewable tablets.
Class II · Moderate risk
Good Neighbor Pharmacy
Presence of foreign substance: small metallic particles in chewable tablets.
Class II · Moderate risk
Good Neighbor Pharmacy
Presence of foreign substance: small metallic particles in chewable tablets.
Class II · Moderate risk
Haleon Calcium Carbonate Tums Antacid
Presence of foreign substance: small metallic particles in chewable tablets.
Class II · Moderate risk
Haleon Calcium Carbonate Tums Antacid
Presence of foreign substance: small metallic particles in chewable tablets.
Class II · Moderate risk
KIRKLAND Signature
Presence of foreign substance: small metallic particles in chewable tablets.
Class II · Moderate risk
Aripiprazole Tablets USP
Product Mix-Up: A bottle containing Voriconazole Tablets 50 mg was labelled and distributed as Aripiprazole Tablets USP 30 mg.
Class II · Moderate risk
Alyacen 7/7/7
Failed Impurities/Degradation Specifications: This recall is being initiated due to out-of-specification results total impurities.
Class II · Moderate risk
Niacin Extended-release Tablets
Failed Dissolution Specifications: during 12M LT stability testing OOS low for Stage 3 dissolution at the 24-hour timepoint.
Class II · Moderate risk
Xyvona (levorphanol tartrate tablets)
Labeling: Not Elsewhere Classified. This recall has been initiated in response to the denial by FDA of marketing the product under the proprietary name Xyvona
Class II · Moderate risk
Xyvona (levorphanol tartrate tablets)
Labeling: Not Elsewhere Classified. This recall has been initiated in response to the denial by FDA of marketing the product under the proprietary name Xyvona
Class II · Moderate risk
Zep, Alcohol Sanitizer Spray
Microbial contamination of sterile products
Class II · Moderate risk
safco SensiCaine-Ultra
Defective container:may contain bottles with incomplete seals
Class II · Moderate risk
PureLife
Defective container:may contain bottles with incomplete seals
Class II · Moderate risk
Dental City TOPICAL ANESTHETIC GEL
Defective container:may contain bottles with incomplete seals
Class II · Moderate risk
Burkhart topical anesthetic gel
Defective container:may contain bottles with incomplete seals
Class II · Moderate risk
DHP Topical Anesthetic Gel
Defective container:may contain bottles with incomplete seals
Class II · Moderate risk
Quala Dental Products
Defective container:may contain bottles with incomplete seals
Class II · Moderate risk
Pearson Quality Topical Anesthetic Gel
Defective container:may contain bottles with incomplete seals
Class II · Moderate risk
Clomiphene Citrate USP Active Pharmaceutical Ingredient
cGMP deviations